NATERA, INC. Selling, General and Administrative Expense
NATERA, INC. (NTRA) reported Selling, General and Administrative Expense of $327.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-07
- NATERA, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $327.20M, a 5.36% increase year-over-year.
- NATERA, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $327.94M, a 22.89% increase year-over-year.
- NATERA, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $291.30M, a 24.00% increase year-over-year.
- NATERA, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $308.55M, a 44.08% increase year-over-year.
- NATERA, INC. selling, general and administrative expense for fiscal 2025 was $1.18B, a 39.93% increase from fiscal 2024.
- NATERA, INC. selling, general and administrative expense for fiscal 2024 was $841.31M, a 36.07% increase from fiscal 2023.
- NATERA, INC. selling, general and administrative expense for fiscal 2023 was $618.31M, a 5.05% increase from fiscal 2022.
- NATERA, INC. selling, general and administrative expense for fiscal 2022 was $588.59M, a 15.18% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $327.20M 10-Q · filed 2026-08-07 | $655.14M 10-Q · filed 2026-08-07 | $946.44M derived: sum of 3 quarters · filed 2026-08-07 | $1.25B derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $327.94M 10-Q · filed 2026-05-08 | $619.24M derived: sum of 2 quarters · filed 2026-05-08 | $927.78M derived: sum of 3 quarters · filed 2026-05-08 | $1.24B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $291.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $599.85M derived: sum of 2 quarters · filed 2026-02-27 | $910.39M derived: sum of 3 quarters · filed 2026-08-07 | $1.18B 10-K · filed 2026-02-27 |
| 2025-09-30 | $308.55M 10-Q · filed 2025-11-07 | $619.10M derived: sum of 2 quarters · filed 2026-08-07 | $885.96M 10-Q · filed 2025-11-07 | $1.12B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $310.55M 10-Q · filed 2026-08-07 | $577.41M 10-Q · filed 2026-08-07 | $812.33M derived: sum of 3 quarters · filed 2026-08-07 | $1.03B derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $266.86M 10-Q · filed 2026-05-08 | $501.78M derived: sum of 2 quarters · filed 2026-05-08 | $715.93M derived: sum of 3 quarters · filed 2026-05-08 | $913.90M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $234.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $449.07M derived: sum of 2 quarters · filed 2026-02-27 | $647.04M derived: sum of 3 quarters · filed 2026-02-27 | $841.31M 10-K · filed 2026-02-27 |
| 2024-09-30 | $214.15M 10-Q · filed 2025-11-07 | $412.12M derived: sum of 2 quarters · filed 2025-11-07 | $606.40M 10-Q · filed 2025-11-07 | $767.83M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $197.97M 10-Q · filed 2025-08-08 | $392.24M 10-Q · filed 2025-08-08 | $553.67M derived: sum of 3 quarters · filed 2026-02-27 | $708.41M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $194.28M 10-Q · filed 2025-05-09 | $355.71M derived: sum of 2 quarters · filed 2026-02-27 | $510.45M derived: sum of 3 quarters · filed 2026-02-27 | $662.96M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $161.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $316.17M derived: sum of 2 quarters · filed 2026-02-27 | $468.68M derived: sum of 3 quarters · filed 2026-02-27 | $618.31M 10-K · filed 2026-02-27 |
| 2023-09-30 | $154.74M 10-Q · filed 2024-11-12 | $307.25M derived: sum of 2 quarters · filed 2024-11-12 | $456.88M 10-Q · filed 2024-11-12 | $600.70M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $152.51M 10-Q · filed 2024-08-09 | $302.13M 10-Q · filed 2024-08-09 | $445.96M derived: sum of 3 quarters · filed 2025-02-28 | $593.62M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $149.63M 10-Q · filed 2024-05-10 | $293.45M derived: sum of 2 quarters · filed 2025-02-28 | $441.12M derived: sum of 3 quarters · filed 2025-02-28 | $590.58M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $143.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $291.49M derived: sum of 2 quarters · filed 2025-02-28 | $440.96M derived: sum of 3 quarters · filed 2025-02-28 | $588.59M 10-K · filed 2025-02-28 |
| 2022-09-30 | $147.67M 10-Q · filed 2023-11-09 | $297.13M derived: sum of 2 quarters · filed 2023-11-09 | $444.77M 10-Q · filed 2023-11-09 | $591.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $149.47M 10-Q · filed 2023-08-04 | $297.10M 10-Q · filed 2023-08-04 | $443.86M derived: sum of 3 quarters · filed 2024-02-29 | $572.35M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $147.63M 10-Q · filed 2023-05-10 | $294.39M derived: sum of 2 quarters · filed 2024-02-29 | $422.88M derived: sum of 3 quarters · filed 2024-02-29 | $550.34M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $146.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $275.25M derived: sum of 2 quarters · filed 2024-02-29 | $402.70M derived: sum of 3 quarters · filed 2024-02-29 | $511.03M 10-K · filed 2024-02-29 |
| 2021-09-30 | $128.49M 10-Q · filed 2022-11-09 | $255.94M derived: sum of 2 quarters · filed 2022-11-09 | $364.27M 10-Q · filed 2022-11-09 | $458.35M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $127.46M 10-Q · filed 2022-08-05 | $235.79M 10-Q · filed 2022-08-05 | $329.87M derived: sum of 3 quarters · filed 2023-03-01 | $405.55M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $108.33M 10-Q · filed 2022-05-06 | $202.41M derived: sum of 2 quarters · filed 2023-03-01 | $278.09M derived: sum of 3 quarters · filed 2023-03-01 | $346.28M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $94.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $169.76M derived: sum of 2 quarters · filed 2023-03-01 | $237.95M derived: sum of 3 quarters · filed 2023-03-01 | $303.63M 10-K · filed 2023-03-01 |
| 2020-09-30 | $75.68M 10-Q · filed 2021-11-05 | $143.87M derived: sum of 2 quarters · filed 2021-11-05 | $209.55M 10-Q · filed 2021-11-05 | $268.13M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $68.19M 10-Q · filed 2021-08-06 | $133.87M 10-Q · filed 2021-08-06 | $192.46M derived: sum of 3 quarters · filed 2022-02-25 | $249.17M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $65.68M 10-Q · filed 2021-05-07 | $124.27M derived: sum of 2 quarters · filed 2022-02-25 | $180.98M derived: sum of 3 quarters · filed 2022-02-25 | $228.03M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $58.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $115.30M derived: sum of 2 quarters · filed 2022-02-25 | $162.34M derived: sum of 3 quarters · filed 2022-02-25 | $206.18M 10-K · filed 2022-02-25 |
| 2019-09-30 | $56.72M 10-Q · filed 2020-11-06 | $103.76M derived: sum of 2 quarters · filed 2020-11-06 | $147.59M 10-Q · filed 2020-11-06 | $188.72M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $47.04M 10-Q · filed 2020-08-07 | $90.87M 10-Q · filed 2020-08-07 | $132.01M derived: sum of 3 quarters · filed 2021-02-26 | $170.38M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $43.83M 10-Q · filed 2020-05-08 | $84.97M derived: sum of 2 quarters · filed 2021-02-26 | $123.34M derived: sum of 3 quarters · filed 2021-02-26 | $160.78M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $41.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $79.51M derived: sum of 2 quarters · filed 2021-02-26 | $116.95M derived: sum of 3 quarters · filed 2021-02-26 | $154.87M 10-K · filed 2021-02-26 |
| 2018-09-30 | $38.37M 10-Q · filed 2019-11-08 | $75.81M derived: sum of 2 quarters · filed 2019-11-08 | $113.74M 10-Q · filed 2019-11-08 | $162.68M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $37.44M 10-Q · filed 2019-08-09 | $75.36M 10-Q · filed 2019-08-09 | $124.30M derived: sum of 3 quarters · filed 2020-03-02 | $158.78M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $37.92M 10-Q · filed 2019-05-10 | $86.86M derived: sum of 2 quarters · filed 2020-03-02 | $121.34M derived: sum of 3 quarters · filed 2020-03-02 | $155.65M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $48.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $83.42M derived: sum of 2 quarters · filed 2020-03-02 | $117.72M derived: sum of 3 quarters · filed 2020-03-02 | $155.31M 10-K · filed 2020-03-02 |
| 2017-09-30 | $34.48M 10-Q · filed 2018-11-09 | $68.79M derived: sum of 2 quarters · filed 2018-11-09 | $106.37M 10-Q · filed 2018-11-09 | $143.92M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $34.31M 10-Q · filed 2018-08-09 | $71.89M 10-Q · filed 2018-08-09 | $109.44M derived: sum of 3 quarters · filed 2019-03-15 | $144.38M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $37.58M 10-Q · filed 2018-05-10 | $75.14M derived: sum of 2 quarters · filed 2019-03-15 | $110.07M derived: sum of 3 quarters · filed 2019-03-15 | $143.30M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $37.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $72.49M derived: sum of 2 quarters · filed 2019-03-15 | $105.72M derived: sum of 3 quarters · filed 2019-03-15 | $136.13M 10-K · filed 2019-03-15 |
| 2016-09-30 | $34.94M 10-Q · filed 2017-11-09 | $68.17M derived: sum of 2 quarters · filed 2017-11-09 | $98.57M 10-Q · filed 2017-11-09 | $129.01M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $33.23M 10-Q · filed 2017-08-09 | $63.63M 10-Q · filed 2017-08-09 | $94.08M derived: sum of 3 quarters · filed 2018-03-15 | $121.95M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $30.41M 10-Q · filed 2017-05-10 | $60.85M derived: sum of 2 quarters · filed 2018-03-15 | $88.72M derived: sum of 3 quarters · filed 2018-03-15 | $116.81M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $30.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $58.31M derived: sum of 2 quarters · filed 2018-03-15 | $86.40M derived: sum of 3 quarters · filed 2018-03-15 | $109.64M 10-K · filed 2018-03-15 |
| 2015-09-30 | $27.87M 10-Q · filed 2016-11-14 | $55.96M derived: sum of 2 quarters · filed 2016-11-14 | $79.19M 10-Q · filed 2016-11-14 | $97.54M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $28.09M 10-Q · filed 2016-08-11 | $51.33M 10-Q · filed 2016-08-11 | $69.67M derived: sum of 3 quarters · filed 2017-03-16 | $85.98M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $23.24M 10-Q · filed 2016-05-13 | $41.59M derived: sum of 2 quarters · filed 2017-03-16 | $57.89M derived: sum of 3 quarters · filed 2017-03-16 | $71.80M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $18.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $34.65M derived: sum of 2 quarters · filed 2017-03-16 | $48.56M derived: sum of 3 quarters · filed 2017-03-16 | $62.94M 10-K · filed 2017-03-16 |
| 2014-09-30 | $16.30M 10-Q · filed 2015-11-13 | $30.21M derived: sum of 2 quarters · filed 2015-11-13 | $44.59M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $13.90M 10-Q · filed 2015-08-13 | $28.28M 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | $31.61M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |